480 related articles for article (PubMed ID: 33808001)
1. Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer.
Telkoparan-Akillilar P; Panieri E; Cevik D; Suzen S; Saso L
Molecules; 2021 Mar; 26(5):. PubMed ID: 33808001
[TBL] [Abstract][Full Text] [Related]
2. The Dual Roles of NRF2 in Cancer.
Menegon S; Columbano A; Giordano S
Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
[TBL] [Abstract][Full Text] [Related]
3. The Role of NRF2/KEAP1 Signaling Pathway in Cancer Metabolism.
Song MY; Lee DY; Chun KS; Kim EH
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922165
[TBL] [Abstract][Full Text] [Related]
4. Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review.
Qin JJ; Cheng XD; Zhang J; Zhang WD
Cell Commun Signal; 2019 Sep; 17(1):121. PubMed ID: 31511020
[TBL] [Abstract][Full Text] [Related]
5. Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression.
Nezu M; Suzuki N; Yamamoto M
Am J Nephrol; 2017; 45(6):473-483. PubMed ID: 28502971
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer.
Kang JS; Nam LB; Yoo OK; Keum YS
Biochem Pharmacol; 2020 Jul; 177():114002. PubMed ID: 32360363
[TBL] [Abstract][Full Text] [Related]
7. An overview of chemical inhibitors of the Nrf2-ARE signaling pathway and their potential applications in cancer therapy.
Zhu J; Wang H; Chen F; Fu J; Xu Y; Hou Y; Kou HH; Zhai C; Nelson MB; Zhang Q; Andersen ME; Pi J
Free Radic Biol Med; 2016 Oct; 99():544-556. PubMed ID: 27634172
[TBL] [Abstract][Full Text] [Related]
8. The Keap1-Nrf2-ARE Pathway As a Potential Preventive and Therapeutic Target: An Update.
Lu MC; Ji JA; Jiang ZY; You QD
Med Res Rev; 2016 Sep; 36(5):924-63. PubMed ID: 27192495
[TBL] [Abstract][Full Text] [Related]
9. The KEAP1-NRF2 pathway: Targets for therapy and role in cancer.
Adinolfi S; Patinen T; Jawahar Deen A; Pitkänen S; Härkönen J; Kansanen E; Küblbeck J; Levonen AL
Redox Biol; 2023 Jul; 63():102726. PubMed ID: 37146513
[TBL] [Abstract][Full Text] [Related]
10. Molecular Basis of the KEAP1-NRF2 Signaling Pathway.
Suzuki T; Takahashi J; Yamamoto M
Mol Cells; 2023 Mar; 46(3):133-141. PubMed ID: 36994473
[TBL] [Abstract][Full Text] [Related]
11. NRF2: KEAPing Tumors Protected.
Pillai R; Hayashi M; Zavitsanou AM; Papagiannakopoulos T
Cancer Discov; 2022 Mar; 12(3):625-643. PubMed ID: 35101864
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic regulation of the NRF2-KEAP1 pathway in human lung cancer.
Camiña N; Penning TM
Br J Cancer; 2022 May; 126(9):1244-1252. PubMed ID: 34845361
[TBL] [Abstract][Full Text] [Related]
13. The Multi-Faceted Consequences of NRF2 Activation throughout Carcinogenesis.
Occhiuto CJ; Moerland JA; Leal AS; Gallo KA; Liby KT
Mol Cells; 2023 Mar; 46(3):176-186. PubMed ID: 36994476
[TBL] [Abstract][Full Text] [Related]
14. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
[TBL] [Abstract][Full Text] [Related]
15. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
[TBL] [Abstract][Full Text] [Related]
16. Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung.
Zhang B; Ma Z; Tan B; Lin N
Expert Opin Ther Targets; 2019 Mar; 23(3):241-250. PubMed ID: 30556750
[TBL] [Abstract][Full Text] [Related]
17. Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution.
Taguchi K; Motohashi H; Yamamoto M
Genes Cells; 2011 Feb; 16(2):123-40. PubMed ID: 21251164
[TBL] [Abstract][Full Text] [Related]
18. Zearalenone induced oxidative stress in the jejunum in postweaning gilts through modulation of the Keap1-Nrf2 signaling pathway and relevant genes1.
Cheng Q; Jiang S; Huang L; Ge J; Wang Y; Yang W
J Anim Sci; 2019 Apr; 97(4):1722-1733. PubMed ID: 30753491
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway.
Zhao S; Song T; Gu Y; Zhang Y; Cao S; Miao Q; Zhang X; Chen H; Gao Y; Zhang L; Han Y; Wang H; Pu J; Xie L; Ji Y
Hepatology; 2021 Jan; 73(1):282-302. PubMed ID: 32219872
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
